| Application no. and date | 19884611.5 (espacenet) (Federated) (European Patent Register), 20191112 | | Patent/reg. no. and date | DK/EP 3880678, 20250507 | | Publication date | 20210922 | | Priority no. and date | US 201862760307 P, 20181113 | | EP pub. no. and date |
EP 3880678 20210922 | | Effective date | | | Applicant/owner | GlaxoSmithKline Intellectual Property (No.3)
Limited, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB | | Applicant ref. no. | V491140DK00 | | Inventor | GARCEAU, Denis, 275, Boulevard Armand-frappier
Laval, QC H7V 4A7, CA,
PAYZA, Kemal, 275, Boulevard Armand-frappier
Laval, QC H7V 4A7, CA,
CHAURET, Nathalie, 275, Boulevard Armand-frappier
Laval, QC H7V 4A7, CA,
WENSLOW, Robert M., 275, Boulevard Armand-frappier
Laval, QC H7V 4A7, CA | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61P 11/14 (2006.01) , A61P 13/00 (2006.01) , A61P 15/00 (2006.01) , A61P 17/04 (2006.01) , A61P 29/00 (2006.01) , C07D 471/04 (2006.01) | | Title | KRYSTALLINSKE FORMER AF P2X3-MODULATOR METHYL(S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLIN-4-CARBOXYLAT | | Int. application no. | IB2019001199 | | Int. publication no. | WO2020099923 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
